JaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottle
Published April 30, 2014 · Recall initiated: May 20, 2013
Summary
FDA records drug Class I recall D-1249-2014, published April 30, 2014 and initiated May 20, 2013. Recalling firm: Dolphin Intertrade Corporation; Status: Terminated; Reported quantity: 998 boxes; Lot: Manufacturing Codes: 10.06.2011 Exp. 09.06.2013. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
What to do
Voluntary: Firm initiated · E-Mail
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Dolphin Intertrade Corporation
- Distributor
- Nationwide
- Lot
- Manufacturing Codes: 10.06.2011 Exp. 09.06.2013
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAXIYOUJI QINGZHI CAPSULE, 300mg, 20 count boxApril 30, 2014
- FDARezzRX capsules, Single Blister Pack and 20 count bottle, Distributed By: Fossil Fuel Products, LLC Atlanta,April 30, 2014
- FDANicorette Lozenge and NicoDerm CQ, nicotine polacrilex system. 189 2mg Mint Flavored Lozenges + 21 31 mgApril 30, 2014
- FDAVPRIV® (velaglucerase alfa for injection) , Lyophilized Powder, 400 Units/vial, Rx Only. Shire Human GeneticApril 30, 2014
- FDANicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC.April 30, 2014
- FDAGlycopyrrolate (MDV) 0.2 MG/ML Injectable, 5 mL Vials, Sterile Serum Vials/Sterile Syringes, for use by aApril 30, 2014
Questions about this recall
Was JaDera, 100% Natural Weight Loss Supplement, capsules, 30 count bottle recalled?
Yes. FDA published recall D-1249-2014 on April 30, 2014. Reported hazard: Marketed without an Approved NDA/ANDA: Products found to contain undeclared sibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
What should I do if I have this product?
Voluntary: Firm initiated · E-Mail